This Entry
PermalinkURI
URI Label
Revisions
Add to List
Edit Entry
Export:
XML
Archives
- November 2017 (1)
- July 2017 (1)
- February 2017 (1)
- January 2017 (2)
- May 2016 (1)
- April 2016 (1)
- December 2015 (1)
- November 2015 (2)
- August 2015 (1)
- June 2015 (1)
- May 2015 (3)
- April 2015 (1)
- January 2015 (1)
- December 2014 (1)
- November 2014 (2)
- August 2014 (4)
- July 2014 (2)
- June 2014 (3)
- May 2014 (1)
- April 2014 (3)
- March 2014 (2)
- February 2014 (2)
- January 2014 (1)
- December 2013 (2)
- November 2013 (3)
- September 2013 (1)
- August 2013 (1)
- July 2013 (2)
- June 2013 (2)
- April 2013 (1)
- March 2013 (1)
- February 2013 (2)
- January 2013 (1)
- December 2012 (2)
- November 2012 (1)
- September 2012 (2)
- June 2012 (2)
- April 2012 (4)
- March 2012 (2)
- March 2012 (2)
- January 2012 (3)
Authors
Sections
- 3D7 IC50 Avery Lab (3)
- AstraZeneca (2)
- MetID (3)
- Potencies GSK (1)
- Potencies Guy (1)
- Syngene (8)
- UCSD (1)
- Biology (37)
- DMPK (2)
- Dundee (4)
- GSH-EE - Chapman Lab (2)
- GSK PRR Assay (1)
- Imperial DGFA (1)
- Kirk Lab (5)
- Metabolism (1)
Tools
Show/Hide QR CodeShow/Hide Keys
Frozen plasma samples collected from in vivo plasmodium berghei were assayed for quantity of PMY 10-6 at 1, 4 and 24 hours.
PMY 10-6 has a 3D7 IC50 of 0.4-0.8 μM, therefore ineffective plasma concentrations are reached in under 4 hours.
Data:
See also:
In vivo Plasmodium Berghei mouse trial of initial leads
Human and Mouse Plasma Stability of OSM-S-5/PMY 10-6
Synthesis of TCMDC-123812 via acid chloride (PMY 10-6)
InChi:
InChI=1S/C15H15FN2O3/c1-9-7-13(15(20)21-8-14(17)19)10(2)18(9)12-5-3-11(16)4-6-12/h3-7H,8H2,1-2H3,(H2,17,19)
| Time, h | concentration, ng/mL |
| 1 | 583 |
| 4 | 44.9 |
| 24 | <5.00 |
PMY 10-6 has a 3D7 IC50 of 0.4-0.8 μM, therefore ineffective plasma concentrations are reached in under 4 hours.
Data:
data
See also:
In vivo Plasmodium Berghei mouse trial of initial leads
Human and Mouse Plasma Stability of OSM-S-5/PMY 10-6
Synthesis of TCMDC-123812 via acid chloride (PMY 10-6)
InChi:
InChI=1S/C15H15FN2O3/c1-9-7-13(15(20)21-8-14(17)19)10(2)18(9)12-5-3-11(16)4-6-12/h3-7H,8H2,1-2H3,(H2,17,19)
Linked Posts
This post is linked by:
Attached Files
data
Original data provided by Paul Willis. Numbers in black are the data provided by the analysis. The number in blue is Paul Willis' calculation of the plasma levels (uM). The compounds profile maintains plasma levels above the EC50 for short periods of time (<4 hrs) so this is a likely cause of the lack of in vivo efficacy.
Paul Ylioja email comments: This ties in well with the observed metabolism in mouse plasma (http://malaria.ourexperiment.org/uri/115). 0.2 uM after 4 hours is on the limit of any effect for this compound anyway (3D7 IC50 375-818 nM). Still interesting to see the compound in the blood!
Paul Ylioja email comments: This ties in well with the observed metabolism in mouse plasma (http://malaria.ourexperiment.org/uri/115). 0.2 uM after 4 hours is on the limit of any effect for this compound anyway (3D7 IC50 375-818 nM). Still interesting to see the compound in the blood!